Works matching DE "ANAKINRA"
Results: 125
A single-centre retrospective case series of Anakinra for incident calcium pyrophosphate deposition disease.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Budget impact analysis of anakinra in the treatment of familial Mediterranean fever in Italy.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2176091
- By:
- Publication type:
- Article
Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USA.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 207, n. 2, p. 218, doi. 10.1093/cei/uxab024
- By:
- Publication type:
- Article
IL‐1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 198, n. 1, p. 101, doi. 10.1111/cei.13314
- By:
- Publication type:
- Article
Analysing of The Effects of an Interleukin - 1 Receptor Antagonist and a RNA Polymerase Inhibitor on Neurodegeneration in the Hippocampal Cell Line.
- Published in:
- Cumhuriyet Medical Journal, 2024, v. 46, n. 2, p. 136, doi. 10.7197/cmj.1482552
- By:
- Publication type:
- Article
A systems pharmacology workflow with experimental validation to assess the potential of anakinra for treatment of focal and segmental glomerulosclerosis.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0214332
- By:
- Publication type:
- Article
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 1, p. 151, doi. 10.3899/jrheum.220213
- By:
- Publication type:
- Article
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis.
- Published in:
- Signa Vitae, 2023, v. 19, n. 5, p. 47, doi. 10.22514/sv.2023.025
- By:
- Publication type:
- Article
Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C).
- Published in:
- Indian Pediatrics, 2021, v. 58, n. 10, p. 994, doi. 10.1007/s13312-021-2340-1
- By:
- Publication type:
- Article
Analysis of Anakinra Therapy for the Deficiency of Interleukin-1 Receptor Antagonist through Clinical Evidence.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 4, p. 1026, doi. 10.3390/jcm13041026
- By:
- Publication type:
- Article
Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 19, p. 5799, doi. 10.3390/jcm11195799
- By:
- Publication type:
- Article
The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 19, p. 4462, doi. 10.3390/jcm10194462
- By:
- Publication type:
- Article
Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19 †.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 4019, doi. 10.3390/jcm10174019
- By:
- Publication type:
- Article
Anakinra and dexamethasone treatment of idarubicin‐induced mucositis and diarrhoea in rats.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 132, n. 6, p. 511, doi. 10.1111/bcpt.13851
- By:
- Publication type:
- Article
Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis.
- Published in:
- European Journal of Medical Research, 2023, v. 28, n. 1, p. 1, doi. 10.1186/s40001-023-01072-z
- By:
- Publication type:
- Article
Successful treatment of cutaneous-onset Erdheim–Chester disease with cobimetinib and anakinra.
- Published in:
- Clinical & Experimental Dermatology, 2024, v. 49, n. 5, p. 523, doi. 10.1093/ced/llae014
- By:
- Publication type:
- Article
Successful treatment with anakinra in generalized spiculated porokeratosis and severe hidradenitis suppurativa in a patient with MVK and MEFV mutations.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 2, p. 161, doi. 10.1093/ced/llac023
- By:
- Publication type:
- Article
Anakinra for recalcitrant pyoderma gangrenosum.
- Published in:
- Clinical & Experimental Dermatology, 2021, v. 46, n. 8, p. 1558, doi. 10.1111/ced.14809
- By:
- Publication type:
- Article
The Beneficial Outcome of Subsequent Treatment with Anakinra during the Chronic Phase of Febrile Infection-Related Epilepsy Syndrome (FIRES): A Case Report.
- Published in:
- Neurology International, 2023, v. 15, n. 4, p. 1489, doi. 10.3390/neurolint15040097
- By:
- Publication type:
- Article
Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study.
- Published in:
- Pediatric Rheumatology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00924-6
- By:
- Publication type:
- Article
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
- Published in:
- Pediatric Rheumatology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00858-z
- By:
- Publication type:
- Article
Late Acute Cellular Rejection After Anakinra Treatment in a Kidney Transplant Patient, Is It a Coincidence?
- Published in:
- 2020
- By:
- Publication type:
- journal article
An allosteric interleukin-1 receptor modulator mitigates inflammation and photoreceptor toxicity in a model of retinal degeneration.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series.
- Published in:
- Dermatology (10188665), 2023, v. 239, n. 1, p. 72, doi. 10.1159/000525987
- By:
- Publication type:
- Article
Pyoderma Gangrenosum and Interleukin Inhibitors: A Semi-Systematic Review.
- Published in:
- Dermatology (10188665), 2022, v. 238, n. 4, p. 785, doi. 10.1159/000519320
- By:
- Publication type:
- Article
Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
- Published in:
- 2022
- By:
- Publication type:
- Letter
The Effect of Anakinra on Paclitaxel-Induced Peripheral Neuropathic Pain in Rats.
- Published in:
- Turkish Journal of Anesthesia & Reanimation, 2016, v. 44, n. 6, p. 287, doi. 10.5152/TJAR.2016.02212
- By:
- Publication type:
- Article
Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 8, p. 1129, doi. 10.3390/cells12081129
- By:
- Publication type:
- Article
Treatment With Anakinra After Initially Receiving Tocilizumab for Cytokine Release Syndrome.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 6, p. 1
- By:
- Publication type:
- Article
Anakinra Used in a Patient with Diffuse Large B-Cell Lymphoma and Steroid-Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome: Case Report.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 1, p. 50
- By:
- Publication type:
- Article
Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 10, p. 2036, doi. 10.3390/v15102036
- By:
- Publication type:
- Article
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0295838
- By:
- Publication type:
- Article
Intravenous administration of anakinra in children with macrophage activation syndrome.
- Published in:
- Pediatric Rheumatology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12969-021-00585-3
- By:
- Publication type:
- Article
Successful treatment of pyoderma gangrenosum associated with IgA gammopathy with the IL‐1 receptor antagonist anakinra.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 7, p. e447, doi. 10.1111/jdv.17204
- By:
- Publication type:
- Article
The effect of etanercept and anakinra on experimental type 2 diabetes pathology in rats.
- Published in:
- Acta Veterinaria Brno, 2021, v. 90, n. 4, p. 421, doi. 10.2754/avb202190040421
- By:
- Publication type:
- Article
Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Anakinra in Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Medical Sciences, 2023, v. 11, n. 1, p. 4, doi. 10.3390/medsci11010004
- By:
- Publication type:
- Article
Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids.
- Published in:
- Microorganisms, 2021, v. 9, n. 7, p. 1393, doi. 10.3390/microorganisms9071393
- By:
- Publication type:
- Article
Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 12, p. 2990, doi. 10.1002/ccr3.3307
- By:
- Publication type:
- Article
The Factors Affecting the Efficacy of Interleukin-1 Receptor Antagonists in COVID-19 Patients.
- Published in:
- Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi, 2022, v. 75, n. 3, p. 400, doi. 10.4274/atfm.galenos.2022.49354
- By:
- Publication type:
- Article
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 6, p. 645, doi. 10.1007/s40272-020-00421-3
- By:
- Publication type:
- Article
Effect of the IL-1 Receptor Antagonist Kineret<sup>®</sup> on Disease Phenotype in mdx Mice.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155944
- By:
- Publication type:
- Article
A rare cause of AA amyloidosis: Glomus tumor and treatment with anakinra—Case report and literature review.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 1, p. 1, doi. 10.1111/1756-185X.14984
- By:
- Publication type:
- Article
Successful use of subcutaneous anakinra in hemophagocytic lymphohistiocytosis precipitated by candidiasis in a patient with systemic lupus erythematosus: A case report and description of a novel therapeutic regimen.
- Published in:
- International Journal of Rheumatic Diseases, 2023, v. 26, n. 11, p. 2284, doi. 10.1111/1756-185X.14722
- By:
- Publication type:
- Article
An unusual presentation of immunoglobulin A gammopathy in a patient with Schnitzler's syndrome.
- Published in:
- International Journal of Rheumatic Diseases, 2023, v. 26, n. 10, p. 2085, doi. 10.1111/1756-185X.14718
- By:
- Publication type:
- Article
Effectiveness of early Anakinra on cardiac function in children with multisystem inflammatory syndrome of COVID-19: a systematic review.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09581-w
- By:
- Publication type:
- Article
The efficacy of a single-dose anakinra injection during disease attack in pediatric familial Mediterranean fever.
- Published in:
- Rheumatology International, 2024, v. 44, n. 11, p. 2569, doi. 10.1007/s00296-023-05351-0
- By:
- Publication type:
- Article
Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
- Published in:
- Rheumatology International, 2022, v. 42, n. 1, p. 81, doi. 10.1007/s00296-021-04997-y
- By:
- Publication type:
- Article
Are YouTube videos enough to learn anakinra self-injection?
- Published in:
- Rheumatology International, 2021, v. 41, n. 12, p. 2125, doi. 10.1007/s00296-021-04999-w
- By:
- Publication type:
- Article